Fisher & Paykel Healthcare seeing ‘good growth’ across hospital products

Saroj Kumar
3 Min Read


No caption


Photo:

Fisher & Paykel Healthcare has upped its full year revenue and profit guidance on the back of “good growth” in its full range of hospital products.

“We have continued to see good growth across the full range of our hospital products so far during our second half,” managing director Lewis Gradon said.

“While relative seasonal respiratory hospitalisations in the northern hemisphere winter may continue to impact the second half result, our performance to date suggests pleasing progress in our efforts to change clinical practice.

“Continuous improvement activities and other efficiency gains are also contributing to improvements in our gross margin and operating margin.”

23 February 2026 guidance* versus 29 November 2025

  • Net profit $450m – $470m vs $410m – $460m
  • Revenue $2.30b vs $2.17b – $2.27b
  • Assumes US exchange rate of 60 US cents vs 57 US cents
  • Does not incorporate any potential refund of US tariffs paid to date during the 2026 financial year.

Update on US tariffs

The company updated its view on US tariffs following a US Supreme Court decision invalidating tariffs imposed by the US administration under the International Emergency Economic Powers Act (IEEPA).

“There are still a number of uncertainties regarding the implications of the Supreme Court’s ruling for companies that import into the United States,” it said.

“The company continues to work through the complexities associated with the US court rulings, refund processes and application of free trade agreements and the Nairobi Protocol to its products, and will provide an update on tariff impacts with its full year results at the end of May.”

The company continued to view the current and proposed tariff structures in the context of cost increases that will be mitigated over time by the company’s long-standing continuous improvement activities.

“As such, the company does not currently believe these matters have any material impact on the company’s long-term direction, strategy or sustainable profitable growth.”

F&P declined to comment further.

Sign up for Ngā Pitopito Kōrero, a daily newsletter curated by our editors and delivered straight to your inbox every weekday.



Source link

Share This Article
Follow:
Saroj Kumar is a digital journalist and news Editor, of Aman Shanti News. He covers breaking news, Indian and global affairs, and trending stories with a focus on accuracy and credibility.